Recent Quarter Total Invested
$688.14 M
Recent Quarter Institutional Ownership Percentage
89.42%
Total Invested of Last Quarter
$415.42 M
Ownership Percentage of Last Quarter
84.82%
Terns Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 08/14/2024 | 7.62 M | $51.89 M | 0.00% | 10.23% |
| VIVO CAPITAL, LLC | 08/14/2024 | 6.18 M | $42.11 M | -7.13% | 8.30% |
| DEEP TRACK CAPITAL, LP | 08/14/2024 | 6.10 M | $41.54 M | 0.00% | 8.19% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 4.95 M | $33.69 M | 100.00% | 6.64% |
| BLACKROCK INC. | 08/13/2024 | 4.12 M | $28.06 M | 24.28% | 5.53% |
| VR ADVISER, LLC | 08/14/2024 | 3.41 M | $23.22 M | 0.00% | 4.58% |
| FMR LLC | 08/13/2024 | 2.77 M | $18.84 M | 0.18% | 3.72% |
| POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 2.69 M | $18.32 M | 21.12% | 3.61% |
| VANGUARD GROUP INC | 08/13/2024 | 2.30 M | $15.67 M | 4.64% | 3.09% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 2.27 M | $15.45 M | 89.70% | 3.05% |
| CITADEL ADVISORS LLC | 08/14/2024 | 1.46 M | $9.94 M | -50.77% | 1.96% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2024 | 1.36 M | $9.29 M | 118.30% | 1.83% |
| STATE STREET CORP | 08/14/2024 | 1.18 M | $8.01 M | 29.97% | 1.58% |
| GREAT POINT PARTNERS LLC | 08/14/2024 | 1.15 M | $7.83 M | -12.26% | 1.54% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 1.14 M | $7.77 M | -66.78% | 1.53% |
| FRANKLIN RESOURCES INC | 08/14/2024 | 1.12 M | $7.65 M | -52.86% | 1.51% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.12 M | $7.64 M | 29.56% | 1.51% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/15/2024 | 1.08 M | $7.38 M | 0.00% | 1.46% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 975,000 | $6.64 M | 14.71% | 1.31% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 08/14/2024 | 956,542 | $6.51 M | 100.00% | 1.28% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 08/14/2024 | 748,996 | $5.10 M | -63.28% | 1.01% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 747,442 | $5.09 M | 368.40% | 1.00% |
| WOODLINE PARTNERS LP | 08/14/2024 | 745,044 | $5.07 M | 100.00% | 1.00% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 698,714 | $4.76 M | 237.57% | 0.94% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/08/2024 | 648,116 | $4.41 M | 2.39% | 0.87% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 08/08/2024 | 621,643 | $92.18 M | -10.95% | 0.83% |
| IKARIAN CAPITAL, LLC | 08/14/2024 | 458,497 | $3.12 M | 418.09% | 0.62% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/08/2024 | 428,956 | $63.60 M | -18.66% | 0.58% |
| ROBECO SCHWEIZ AG | 08/08/2024 | 411,274 | $60.99 M | -23.87% | 0.55% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2024 | 390,270 | $2.66 M | 100.00% | 0.52% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 371,892 | $2.53 M | 9.37% | 0.50% |
| SALEM INVESTMENT COUNSELORS INC | 07/11/2024 | 371,600 | $2.53 M | 100.00% | 0.50% |
| ACUTA CAPITAL PARTNERS, LLC | 08/14/2024 | 369,280 | $2.51 M | -20.60% | 0.50% |
| CITIGROUP INC | 08/12/2024 | 361,080 | $2.46 M | 129.17% | 0.48% |
| NORTHERN TRUST CORP | 08/14/2024 | 347,767 | $2.37 M | -2.26% | 0.47% |
| MORGAN STANLEY | 10/17/2024 | 333,618 | $2.27 M | -43.15% | 0.45% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 298,064 | $2.03 M | 1,451.61% | 0.40% |
| EVERSEPT PARTNERS, LP | 08/14/2024 | 286,266 | $1.95 M | 1.14% | 0.38% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 276,737 | $1.88 M | 621.35% | 0.37% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 258,900 | $1.76 M | 155.33% | 0.35% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 08/12/2024 | 254,684 | $1.73 M | 100.00% | 0.34% |
| BRIDGER MANAGEMENT, LLC | 08/14/2024 | 246,800 | $1.68 M | 0.00% | 0.33% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 224,176 | $1.53 M | 29.88% | 0.30% |
| SAMSARA BIOCAPITAL, LLC | 08/14/2024 | 202,348 | $1.38 M | 0.00% | 0.27% |
| BARCLAYS PLC | 08/14/2024 | 195,442 | $1.33 M | -21.29% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 176,673 | $1.20 M | 56.83% | 0.24% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2024 | 166,640 | $1.13 M | 979.83% | 0.22% |
| NEOS INVESTMENT MANAGEMENT LLC | 08/14/2024 | 165,221 | $1.13 M | 100.00% | 0.22% |
| JPMORGAN CHASE & CO | 08/12/2024 | 153,080 | $1.04 M | -63.69% | 0.21% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 152,720 | $1.04 M | 33.25% | 0.21% |
Terns Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of TERN shares?
During the previous two years, 173 institutional investors and hedge funds held shares of Terns Pharmaceuticals, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 7.56 M
Vivo Capital, LLC: 6.9 M
Soleus Capital Management, L.P.: 6.22 M
Deep Track Capital, LP: 5.58 M
BlackRock Funding, Inc. /DE: 4.7 M
CITADEL ADVISORS LLC: 3.67 M
-
What percentage of Terns Pharmaceuticals, Inc. stock is owned by institutional investors?
89.42% of Terns Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at TERN ?
Institutional investors have bought a total of 78.03 M shares in the last 24 months. This purchase volume represents approximately $446.36 M in transactions.